Syndax Pharmaceuticals SNDX
$8.72 −$0.41 (-4.49%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $8.72 0.00%
Open$9.07
Prev close$9.13
Day range$8.69 – $9.27
Volume2.18M
Market cap$785.05M
P/E (TTM)–
Dividend yield–
Fundamentals
Latest reported quarter: Q3, ended Sep 2026
Revenue$83.30M+81.6% YoY
Operating profit-$41.90M+27.0% YoY
Net profit-$49.43M+18.6% YoY
Diluted EPS-$0.55+21.4% YoY
Free cash flow-$27.25M+61.4% YoY
Operating cash flow-$27.25M
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Gross margin92.2%
Operating margin-61.7%
Net margin-72.3%
Return on equity-426.4%
Return on assets-33.7%
Return on invested capital-104.1%
Current ratio4.69
Liabilities / assets102.5%
Cash & investments$427.10M
Total debt$244.79M
Net cash (debt)$182.31M
Income statement
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Revenue as Reported | $83.30M | $72.79M | $64.86M | $172.35M | $68.73M |
| Total Operating Revenue | $83.30M | $72.79M | $64.86M | $172.35M | $68.73M |
| Cost of Revenue | $14.00M | $3.21M | $2.63M | $6.97M | $2.71M |
| Gross Profit | $69.30M | $69.58M | $62.23M | $165.38M | $66.02M |
| Operating Expense | $111.20M | $109.58M | $96.43M | $438.47M | $128.57M |
| Selling and Admin Expenses | $43.72M | $41.54M | $37.59M | $179.68M | $49.93M |
| -General & Admin Expense | $43.72M | $41.54M | $37.59M | $179.68M | $49.93M |
| Research & Development | $67.48M | $68.04M | $58.85M | $258.78M | $78.64M |
| Operating Profit | -$41.90M | -$40.00M | -$34.20M | -$273.08M | -$62.55M |
| Net Non-Operating Interest Income (Expense) | -$7.39M | -$8.93M | -$8.29M | -$11.06M | -$5.27M |
| Non-Operating Interest Income | $5.59M | $3.75M | $3.56M | $22.73M | $4.33M |
| Non-Operating Interest Expense | $12.98M | $12.68M | $11.85M | $33.79M | $9.59M |
| Other Income (Expense) | -$153,000.00 | -$438,000.00 | -$186,000.00 | -$1.28M | -$201,000.00 |
| Other Non-Operating Income (Expenses) | -$153,000.00 | -$438,000.00 | -$186,000.00 | -$1.28M | -$201,000.00 |
| Pretax Profit | -$49.43M | -$49.36M | -$42.67M | -$285.42M | -$68.01M |
| Net Profit | -$49.43M | -$49.36M | -$42.67M | -$285.42M | -$68.01M |
| Profit from Continuing Operations | -$49.43M | -$49.36M | -$42.67M | -$285.42M | -$68.01M |
| Net Income to Parent Company | -$49.43M | -$49.36M | -$42.67M | -$285.42M | -$68.01M |
| Net Income to Common Stockholders | -$49.43M | -$49.36M | -$42.67M | -$285.42M | -$68.01M |
| Basic EPS | -$0.55 | -$0.55 | -$0.48 | -$3.29 | -$0.78 |
| Diluted EPS | -$0.55 | -$0.55 | -$0.48 | -$3.29 | -$0.78 |
Balance sheet
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Assets | $692.67M | $703.65M | $472.67M | $529.71M | $529.71M |
| Total Current Assets | $567.44M | $675.04M | $471.18M | $528.08M | $528.08M |
| Cash and Cash Equivalents & Short-Term Investments | $427.10M | $547.86M | $352.06M | $394.07M | $394.07M |
| -Cash and Cash Equivalents | $135.94M | $336.48M | $130.89M | $134.93M | $134.93M |
| -Short Term Investments | $291.16M | $211.38M | $221.17M | $259.14M | $259.14M |
| Receivables | $79.78M | $72.79M | $60.69M | $70.29M | $70.29M |
| -Accounts Receivable | $46.87M | $45.07M | $38.12M | $38.00M | $38.00M |
| -Accrued Interest Receivable | $3.07M | $2.66M | $1.80M | $2.15M | $2.15M |
| -Other Receivables | $29.85M | $25.06M | $20.77M | $30.15M | $30.15M |
| Prepaid Assets | $18.22M | $18.81M | $21.20M | $29.75M | $29.75M |
| Inventory | $39.38M | $33.16M | $34.95M | $32.75M | $32.75M |
| Other Current Assets | $2.95M | $2.42M | $2.27M | $1.22M | $1.22M |
| Total Non-Current Assets | $125.24M | $28.61M | $1.49M | $1.63M | $1.63M |
| Net PPE | $1.16M | $1.29M | $1.39M | $1.52M | $1.52M |
| -Gross PPE | $1.60M | $1.73M | $1.82M | $1.95M | $1.95M |
| -Accumulated Depreciation | -$440,000.00 | -$434,000.00 | -$429,000.00 | -$425,000.00 | -$425,000.00 |
| Investments and Advances | $123.98M | $27.22M | – | $0.00 | $0.00 |
| -Available for Sale Securities | $123.98M | – | – | – | – |
| Other Non-Current Assets | $102,000.00 | $102,000.00 | $102,000.00 | $102,000.00 | $102,000.00 |
| Total Liabilities | $709.85M | $688.55M | $431.05M | $465.08M | $465.08M |
| Total Current Liabilities | $120.96M | $99.68M | $86.17M | $120.12M | $120.12M |
| Payables | $12.91M | $13.06M | $18.30M | $23.95M | $23.95M |
| -Accounts Payable | $3.57M | $4.87M | $10.84M | $16.58M | $16.58M |
| -Other Payable | $9.34M | $8.18M | $7.46M | $7.37M | $7.37M |
| Current Accrued Expenses | $79.69M | $62.07M | $49.18M | $60.81M | $60.81M |
| Short-Term Debt and Capital Lease Obligation | $526,000.00 | $506,000.00 | $488,000.00 | $472,000.00 | $472,000.00 |
| -Current Capital Lease Obligation | $526,000.00 | $506,000.00 | $488,000.00 | $472,000.00 | $472,000.00 |
| Current Provisions | $11.71M | $11.12M | $10.11M | $9.81M | $9.81M |
| Other Current Liabilities | $1.96M | $1.55M | $1.27M | $721,000.00 | $721,000.00 |
| Total Non-Current Liabilities | $588.89M | $588.88M | $344.87M | $344.96M | $344.96M |
| Long Term Debt and Capital Lease Obligation | $244.79M | $244.85M | $907,000.00 | $1.05M | $1.05M |
| -Long Term Debt | $244.19M | $244.09M | $343.97M | $343.91M | $343.91M |
| -Long Term Capital Lease Obligation | $607,000.00 | $760,000.00 | $907,000.00 | $1.05M | $1.05M |
| Other Non-Current Liabilities | $344.10M | $344.03M | $343.97M | $343.91M | $343.91M |
| Total Equity | -$17.18M | $15.10M | $41.62M | $64.63M | $64.63M |
| Stockholders' Equity | -$17.18M | $15.10M | $41.62M | $64.63M | $64.63M |
| Capital Stock | $9,000.00 | $9,000.00 | $9,000.00 | $9,000.00 | $9,000.00 |
| -Common Stock | $9,000.00 | $9,000.00 | $9,000.00 | $9,000.00 | $9,000.00 |
| Additional Paid-In Capital | $1.63B | $1.61B | $1.59B | $1.57B | $1.57B |
| Retained Earnings | -$1.65B | -$1.60B | -$1.55B | -$1.51B | -$1.51B |
| Gains/Losses Not Affecting Retained Earnings | -$1.67M | -$140,000.00 | $11,000.00 | $452,000.00 | $452,000.00 |
| -Preferred Stock | – | – | $0.00 | $0.00 | $0.00 |
Cash flow
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Operating Cash Flow | -$27.25M | -$30.27M | -$50.35M | -$322.98M | -$69.49M |
| Net cash flow from continuing operations | -$27.25M | -$30.27M | -$50.35M | -$322.98M | -$69.49M |
| Net Income from Continuing Operations | -$49.43M | -$49.36M | -$42.67M | -$285.42M | -$68.01M |
| Depreciation & Depletion & Amortization | $6,000.00 | $5,000.00 | $4,000.00 | $6,000.00 | $3,000.00 |
| Other Non-Cash Items | $1.47M | $988,000.00 | $186,000.00 | $1.34M | $557,000.00 |
| Change in Working Capital | $7.01M | $4.79M | -$19.05M | -$79.32M | -$11.76M |
| -Change in Receivables | $207,000.00 | -$9.39M | $6.02M | -$79.81M | -$61.97M |
| -Change in Inventory | -$6.02M | $1.84M | -$2.06M | -$32.09M | -$7.80M |
| -Change in Prepaid Assets | -$354,000.00 | $1.39M | $7.84M | -$14.54M | -$5.40M |
| -Change in Payables and Accrued Expense | $19.97M | $12.80M | -$34.09M | $47.12M | $28.45M |
| -Change In Other Working Capital | -$6.79M | -$1.85M | $3.24M | – | – |
| Net cash flow from investing | -$176.47M | -$16.91M | $38.39M | $290.04M | $81.58M |
| Net Cash Flow from Continuing Investing Activities | -$176.47M | -$16.91M | $38.39M | $290.04M | $81.58M |
| Net PPE Purchase and Sale | $0.00 | – | – | -$187,000.00 | -$56,000.00 |
| Net Investment Purchase and Sale | -$176.47M | -$16.87M | $38.39M | $290.22M | $81.63M |
| Financing Cash Flow | $3.19M | $252.77M | $7.92M | $13.68M | $5.92M |
| Net Cash Flow from Continuing Financing Activities | $3.19M | $252.77M | $7.92M | $13.68M | $5.92M |
| Net Issuance Payments Of Debt | $0.00 | – | – | – | – |
| Proceeds from Stock Option Exercised | $3.20M | $8.92M | $7.92M | $13.68M | $5.92M |
| Net Other Financing Charges | -$13,000.00 | – | – | – | – |
| Ending Cash Balance | $136.04M | $336.58M | $131.00M | $135.03M | $135.03M |
| Net Change in Cash | -$200.54M | $205.58M | -$4.04M | -$19.27M | $18.01M |
| Beginning Cash Balance | $336.58M | $131.00M | $135.03M | $154.30M | $117.03M |
| Free Cash Flow | -$27.25M | -$30.31M | -$50.35M | -$323.17M | -$69.54M |
| -Change in Other Current Assets | – | – | – | $0.00 | $0.00 |
| Net Common Stock Issuance | – | – | – | $0.00 | – |
No comments yet — be the first to weigh in on SNDX.
Sign in to join the discussion.